Modified HPLC-electrospray ionization/mass spectrometry method for HbA1c based on IFCC reference measurement
Patricia Kaiser1, Theodorus Akerboom, Petra Molnar
1Reference Measurement Laboratory, Instand e.V., Düsseldorf, Germany. kaiser@instand-ev.de
Clinical Chemistry
|April 12, 2008
Summary
This study enhances hemoglobin A1c (HbA1c) monitoring for diabetes management. The improved HPLC-ESI/MS method offers greater accuracy and stability for HbA1c determination.
Area of Science:
- Clinical Chemistry
- Analytical Chemistry
- Mass Spectrometry
Background:
- Accurate hemoglobin A1c (HbA1c) monitoring is crucial for diabetes mellitus management.
- The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) reference procedure involves enzymatic digestion and peptide analysis.
- Existing methods require enhancement for improved performance and reliability.
Purpose of the Study:
- To develop and validate a modified reference measurement procedure for HbA1c determination.
- To improve upon the existing IFCC reference method using advanced analytical techniques.
Main Methods:
- Modification of the IFCC reference method incorporating High-Performance Liquid Chromatography (HPLC) coupled with Electrospray Ionization/Mass Spectrometry (ESI/MS).
- Chromatographic separation of hemoglobin beta-chain N-terminal hexapeptides using a C12 reversed-phase column and a binary gradient system (H2O/acetonitrile/formic acid).
Main Results:
- The modified HPLC-ESI/MS method demonstrated significantly higher signal intensities and enhanced system stability compared to the original reference procedure.
- Intralaboratory coefficients of variation (CVs) ranged from 0.71% to 1.86% for HbA1c levels between 3% and 14%.
- Deviations from IFCC target values were within -0.87% to 1.00%, meeting the stringent acceptability criteria for HbA1c standardization.
Conclusions:
- The developed HPLC-ESI/MS procedure represents a significant improvement over the existing IFCC reference measurement procedure for HbA1c.
- This enhanced method provides a more robust and accurate platform for clinical HbA1c measurements, aiding in diabetes patient management.

